-
NSE
2,251.00 2,251.00(%) -
HDFC Bank
850.20 1,017.90(%) -
Maruti Suzuki
14,044.00 17,371.60(%) -
Prestige Estates
1,687.90 1,740.85(%) -
M & M
3,568.75 3,840.00(%) -
Shadowfax Technologies
296.85 98.60(%) -
ICICI AMC
2,988.00 3,609.85(%) -
Page Industries
30,665.05 29,800.00(%) -
SBI
1,174.75 1,234.80(%) -
Kotak Mah. Bank
516.45 516.45(%) -
Coforge
2,178.05 2,178.05(%) -
Max Financial
1,432.90 1,891.35(%) -
Cummins India
4,038.50 3,883.30(%) -
Axis Bank
1,448.00 1,448.00(%) -
One 97
1,770.00 1,958.80(%) -
IndusInd Bank
1,005.00 1,077.80(%) -
Reliance Industries
1,382.55 1,611.20(%) -
Nip. India Gold
100.13 100.13(%) -
APL Apollo Tubes
2,038.00 1,691.05(%) -
Multi Comm. Exc.
3,493.15 1,931.20(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Ipca Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 3617.0
- ISIN : INE571A01038
-
Today’s Low
1,825.10 -
Today’s High
1,879.00
-
Open
1,855.20 -
Perv Close
1,860.00 -
52W Low
1,361.70 -
52W High
2,038.00
Key Indicators
-
P/E(TTM)
34.71
-
Mar.Cap (₹Cr.)
46,777.98
-
Div & Yield %
0.33
-
Book Value(₹)
338.05
-
Debt-Equity Ratio
-0.87
-
AGM Date
20-Nov-2026
-
EPS
53.15
-
P/E Ratio
34.71
Financials Ratios
-
Debt-Equity Ratio
0.24
-
Mar.Cap (₹Cr.)
46,777.98
-
RONW (%)
8.69
-
ROCE (%)
12.92
Score Board
-
Equity (₹ in Cr.)
25.37
-
BV (₹)
338.10
-
Sales( ₹ in Cr.)
7,336.75
-
NP (in Cr.)
1,135.98
-
NP Var(%)
38.0
-
Div%
600.0
-
CPS (₹)
55.40
-
EPS (₹)
44.80
-
Traded Value (₹ in Lakhs)
46,809.70
-
52 Week High
2,038.00
-
52 Week Low
1,361.70
-
Price BSE
1845.0
-
Price NSE
1,844.00
-
Market Capital( in Cr.)
46,809.70
-
P/C Ratio
33.30
-
P/E Ratio
41.20
-
Price Vs.BV
44.80
-
17-Nov-2026( 01:35)
Hot Pursuit - Ipca... - <p>Ipca Laboratories Ltd dropp...
-
06-Nov-2026( 10:55)
Results - Announcements - Ipca... - <p>Ipca Laboratories Ltd share...
-
22-Oct-2026( 12:19)
Corporate News - Ipca... - <p>Ipca Laboratories will hold...
-
12-Oct-2026( 03:54)
Corporate News - Ipca... - <p>Ipca Laboratories Limited s...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 7,336.75 | 6,677.92 | 6,166.46 | 5,814.62 | 5,438.30 | 5,139.16 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 7,336.75 | 6,677.92 | 6,166.46 | 5,814.62 | 5,438.30 | 5,139.16 |
| Other Income | 94.64 | 71.29 | 111.29 | 111.19 | 52.92 | 62.24 |
| Stock Adjustments | 60.06 | -128.43 | 55.19 | -104.09 | 126.00 | 170.73 |
| Total Income | 7,491.45 | 6,620.78 | 6,332.94 | 5,821.72 | 5,617.22 | 5,372.13 |
| EXPENDITURE : | ||||||
| Raw Materials | 1,916.84 | 1,764.88 | 2,033.57 | 1,964.94 | 1,911.88 | 1,753.21 |
| Power and Fuel Cost | 250.97 | 235.60 | 253.33 | 277.21 | 237.44 | 201.48 |
| Employee Cost | 1,655.90 | 1,479.34 | 1,336.19 | 1,193.39 | 1,102.14 | 948.84 |
| Other Manufacturing Expenses | 385.83 | 367.61 | 356.81 | 311.74 | 279.03 | 225.25 |
| Selling and Administration Expenses | 1,077.02 | 953.42 | 846.95 | 812.67 | 612.89 | 551.23 |
| Miscellaneous Expenses | 358.43 | 503.13 | 314.87 | 236.31 | 179.67 | 113.31 |
| Employee Benefit Expenses | 1,655.90 | 1,479.34 | 1,336.19 | 1,193.39 | 1,102.14 | 948.84 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 5,644.99 | 5,303.98 | 5,141.72 | 4,796.26 | 4,323.05 | 3,793.32 |
| Operating Profit | 1,846.46 | 1,316.80 | 1,191.22 | 1,025.46 | 1,294.17 | 1,578.81 |
| Interest | 45.46 | 65.06 | 122.58 | 46.34 | 10.41 | 11.13 |
| Gross Profit | 1,801.00 | 1,251.74 | 1,068.64 | 979.12 | 1,283.76 | 1,567.68 |
| Depreciation | 268.87 | 251.97 | 246.48 | 228.63 | 209.65 | 187.72 |
| Profit Before Tax | 1,532.13 | 999.77 | 822.16 | 750.49 | 1,074.11 | 1,379.96 |
| Current Tax | 402.12 | 340.90 | 288.01 | 223.95 | 197.28 | 244.98 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -2.51 | 8.11 | 3.74 | 20.84 | 16.46 | -5.79 |
| Reported Net Profit | 1,132.52 | 650.76 | 530.41 | 505.70 | 860.37 | 1,140.77 |
| Extraordinary Items | -3.46 | -169.55 | -69.52 | 17.51 | 7.86 | 8.34 |
| Adjusted Net Profit | 1,135.98 | 820.31 | 599.93 | 488.19 | 852.51 | 1,132.43 |
| Adjustment below Net Profit | 3.35 | -4.92 | -1.39 | -2.05 | 1.15 | -0.16 |
| P & L Balance brought forward | 5,501.16 | 4,956.80 | 4,478.52 | 4,076.35 | 3,316.31 | 2,277.18 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 50.74 | 101.48 | 50.74 | 101.48 | 101.48 | 101.48 |
| P & L Balance carried down | 6,586.29 | 5,501.16 | 4,956.80 | 4,478.52 | 4,076.35 | 3,316.31 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 600.00 | 400.00 | 400.00 | 400.00 | 400.00 | 400.00 |
| Dividend Per Share(Rs) | 6.00 | 4.00 | 4.00 | 4.00 | 4.00 | 8.00 |
| Earnings Per Share-Unit Curr | 44.64 | 25.65 | 20.91 | 19.93 | 33.91 | 89.93 |
| Earnings Per Share(Adj)-Unit Curr | 44.64 | 25.65 | 20.91 | 19.93 | 33.91 | 44.97 |
| Book Value | 314.52 | 271.64 | 250.24 | 231.66 | 215.84 | 374.67 |
| Book Value(Adj)-Unit Curr | 314.52 | 271.64 | 250.24 | 231.66 | 215.84 | 187.34 |
